We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cytomyx Hldgs | LSE:CYX | London | Ordinary Share | GB0033942276 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.10 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3690A Cytomyx Holdings PLC 24 March 2006 Cytomyx Holldings Plc Appointment of Director Cytomyx Holdings plc (the "Company") announces that Mr Glen Gershon has today joined its board as a director. Glen Arthur Gerson, a US citizen aged 51, is currently the general manager of Cytomyx LLC in Lexington, Massachusetts. Prior to joining the Company, Mr Gershon worked with Ardais Corporation for four years as the Director of Quality and then became Vice President of Biological Operations. Mr Gershon has more than 20 years experience in the life science industry. He has a BS from Eckerd College and an MS in Biological Sciences from Illinois State University. No further information is required to be disclosed under paragraph g of schedule two of the AIM rules. This information is provided by RNS The company news service from the London Stock Exchange END BOAILFEVVIISFIR
1 Year Cytomyx Chart |
1 Month Cytomyx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions